Platelets Structure, Function and Modulator Capacity in Replacement Therapy.

Cardiovasc Hematol Disord Drug Targets

INSA, National Institute of Health Dr. Ricardo Jorge, Department of Health Promotion and Chronic Diseases, Rua Alexandre Herculano, 321, 4000-055 Porto, Portugal.

Published: March 2019

Introduction: Patients with severe thrombocytopenia are presumed to be at increased risk for bleeding, and consequently it has been a standard practice for the past four decades to give allogeneic platelet transfusions to severely thrombocytopenic patients as supportive care. Platelet transfusions may be given either prophylactically to reduce the risk of bleeding, in the absence of clinical hemorrhage (prophylactic transfusions), or to control active bleeding when present (therapeutic transfusions).

Conclusion: Here we review the structure and function of platelets and discuss the mechanisms of alloimmunization to platelet transfusion.

Download full-text PDF

Source
http://dx.doi.org/10.2174/1871529X18666171227152937DOI Listing

Publication Analysis

Top Keywords

structure function
8
risk bleeding
8
platelet transfusions
8
platelets structure
4
function modulator
4
modulator capacity
4
capacity replacement
4
replacement therapy
4
therapy introduction
4
introduction patients
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!